Mozz that was one of your best yet.., I haven't been waiting that long for the stock at all - I'm a covid entry so early days for me. - a mate suggested this stock prior but one among many. My OA is long term they say due to sport - only brought to my attention recently due to trauma - and only diagnosed a month ago - yet I'm bone on bone already. If there is something that works on this prior to bone on bone to slow it up then it will be a massive winner. Forget 15% of the market it will be 30% early, My father just had a his second knee replacement two mates have both had one done already..., This is not a small side disease it is everywhere and if the GPs switch to early diagnosis protocols it will become common tx.
The only thing preventing that outcome is a better alternative than Zilosul. May well occur - stem cell sounds good in theory just not in practice so will be many years in the future. Current alternatives are not healthy for more than a month or two and are that bad that my G.P has a large sign up now saying they do not prescribe the usual list of opiod painkillers at all . not good marketing if thats your business.-
IMO The primary endpoint of the P3 trials is a shoe in , not as the timely purveyor's of suspicion would have us believe ;-) if the results for the football players is replicated stage 4 OA sounds like it could lift the overall scores on pain not reduce despite the smaller representation. But the bar is not that high - we only need to come close to current treatments on Womac pain to get approval and it surpasses them without the addictive mind altering side effects....which is amazing.
Love to try it if I had the chance - perhaps before the second hip goes.?- The toxicity/AE profile should prompt a speed up....given previous usage.....?... yet we wait.......I know.....just paperwork ...the end is assured... only the journey undecided....yade yade yah....but it pisses me off that It could help me and doesn't hurt me yet I'm not allowed to buy it......and being richer now rather than in 4years would also be nice.;-)
PAR Price at posting:
$2.61 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)